Banque Transatlantique Sa Moderna, Inc. Call Options Transaction History
Banque Transatlantique Sa
- $3.93 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MRNA
# of Institutions
922Shares Held
255MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.36 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.31 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$862 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$593 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$246 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...